Holen Sie sich die Stockscreener-App
195.70
2.93%
5.58
Handel nachbörslich:
195.69
-0.010
-0.01%
Schlusskurs vom Vortag:
$190.12
Offen:
$191.6
24-Stunden-Volumen:
2.21M
Relative Volume:
1.50
Marktkapitalisierung:
$9.09B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+6.55%
1M Leistung:
+19.13%
6M Leistung:
+15.80%
1J Leistung:
+51.06%
1-Tages-Spanne:
$190.92
$195.99
1-Wochen-Bereich:
$183.51
$195.99
52-Wochen-Spanne:
$127.11
$195.99
Ishares Biotechnology Etf Stock (IBB) Company Profile
Firmenname
Ishares Biotechnology Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare IBB vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IBB
Ishares Biotechnology Etf
|
195.70 | 9.09B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
368.76 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
744.78 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
748.43 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
300.34 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
712.60 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Biotechnology Etf Aktie (IBB) Neueste Nachrichten
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Yahoo Finance
Healthcare Stocks Got A Late Lift From Big Headlines - Finimize
Greece’s Return and a Chip Meltdown: MSCI World ETF Caught Between Index History and Market Chaos - Ad-hoc-news.de
How Ishares Biotechnology Etf (IBB) Affects Rotational Strategy Timing - Stock Traders Daily
The biotech sector looks ready for a multi-year breakout: Here's what to watch - MSN
The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. - MarketBeat
Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A - ETF Database
Biotech's Silent Resurgence (5-Year Base Breakout) - TradingView
Biotech breakout: iShares Biotechnology ETF hits all-time high - Seeking Alpha
Why Is Natera Stock Gaining Tuesday? - Benzinga
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead? - TradingView
Biotech ETF hits record as AbbVie seals $10.9B Apogee deal - MSN
Sector Update: Healthcare - Moomoo
As AbbVie eyes Apogee, these biotech stocks earn the highest Quant ratings (IBB:NASDAQ) - Seeking Alpha
DFTX Stock Rallies Ahead Of High-Stakes Phase 3 Depression Drug Trial Results — What Investors Need To Know - TradingView
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
Syntax Bio expands Series A to $14.4M, adds leadership and board members (IBB:NASDAQ) - Seeking Alpha
2Seventy Bio Inc (TSVT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CARGO Therapeutics Inc (CRGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CureVac NV (CVAC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors? - The Motley Fool
Anavex Life Sciences Corp (AVXL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
iShares NASDAQ Biotechnology ETF declares quarterly distribution of $0.0238 - MSN
Tevogen Bio Holdings Inc (TVGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inozyme Pharma Inc (INZY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Altimmune Inc (ALT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nautilus Biotechnology Inc (NAUT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arrivent Biopharma Inc (AVBP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Yahoo Finance
IShares TrustiShares Biotechnology ETF announces Quarterly dividend, payable on June 18, 2026 - marketscreener.com
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - TradingView
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Yahoo Finance
IBBm Holdings (iShares Biotechnology Cedear) - Investing.com
Sector Update: Healthcare Stocks Gain Friday Afternoon - Moomoo
BioCardia Jumps After FDA Feedback Seen Positive for CardiAMP Approval - TechStock²
Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Friday After May Jobs Report - Moomoo
Flow Focus | Marvell Ripped, Broadcom Cracked — AI Money Is Getting Pickier - Moomoo
Stock Market Today: Nasdaq 100 Slips As Broadcom Plunges, Bitcoin Hits 4-Month Lows - Benzinga
Recursion Stock Jumps Before Goldman Sachs Event as AI-Drug Trade Gets Fresh Heat - TechStock²
Alnylam Eyes Faster Drug Discovery With AI Partnership Worth Up To $2 Billion - Benzinga
Sector Update: Healthcare Stocks Rise Premarket Thursday - Moomoo
Tectonic Therapeutic Stock Climbs as Broader Market Sinks - Bez Kabli
Kyverna Therapeutics Stock Barely Moves—The Bigger CAR-T Test Is Coming - Bez Kabli
MacroGenics Shares Pop on 2028 Cash Runway Focus - Bez Kabli
Chemomab Drops After Board Changes and CEO Stock Purchase - Bez Kabli
DiaMedica Shares Down Ahead of Stroke Trial Update - Bez Kabli
Aura Biosciences Stock Falls After Eye-Cancer Trial News - Bez Kabli
5 Biggest Biotechnology ETFs in 2026 - Investing News Network
Hot Money Rotates to Keep the Market Running - TheStreet Pro
Design Therapeutics Drops Ahead of Jefferies, Trial Remains in Focus for DSGN - Bez Kabli
Ligand Shares Hold Up in Biotech Rout While XOMA Deal Heads for Investor Vote - Bez Kabli
Finanzdaten der Ishares Biotechnology Etf-Aktie (IBB)
Es liegen keine Finanzdaten für Ishares Biotechnology Etf (IBB) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
0.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):